Full Year 2025 Pharmx Technologies Ltd Earnings Call Transcript
Key Points
- PharmX Technologies Ltd (ASX:PHX) reported a 13% increase in total revenues, reaching $7.53 million, driven by strong growth in both gateway and marketplace revenues.
- The company achieved a nearly 200% increase in marketplace revenues, indicating significant expansion in this area.
- Gross transaction volumes (GTV) increased by 18% year-on-year, showcasing robust platform growth.
- PharmX Technologies Ltd (ASX:PHX) maintained a strong gross margin with a 1% increase, despite substantial investments in people and technology.
- The company successfully integrated with market leaders like Toniq, securing access to 99% of the New Zealand market, and expanded its network of suppliers by 16%.
- Operating costs increased by $1.1 million, driven by investments in development resources, sales, marketing, and IT infrastructure.
- EBITDA decreased to $1.6 million from $1.8 million in the prior period, partly due to increased investments.
- The company reported a net loss after tax of $264,000, although this was an improvement from the previous year's loss of $1.8 million.
- The statutory operating cash flow showed an outflow of $8.1 million, primarily due to a $9.9 million payment related to a legal settlement with Fred IT.
- Revenue growth slowed in the second half of the year, attributed to the decision to launch a new single platform, which impacted proactive recruitment of new suppliers.
Good morning, all. Thank you for those who joined early and waiting. Welcome, everyone, who's just joined. So today, we will be going through the PharmX FY25 results presentation. My name is Tom Culver. I'm the CEO. We also have Zoe Hillier, our CFO, presenting today. We'll be taking you through our FY25 financial and platform metrics, some business highlights as well as P&L and cash flow. I'll also be providing an overview of the business and our FY26 strategy.
You'll note in the pack that we have provided a fairly detailed appendix. So should you want any additional details on, say, platform metrics, transactional insights or deeper understanding of our services, you will find that detail in the appendix. However, of course, we will leave time for Q&A. So please throughout the presentation, (Operator Instructions). So without further ado, we are very pleased to announce strong results for the year-end 30 June 2025.
We've had a very positive and strong results on our revenues, with a 13% increase of total revenues
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

